What are the changes to Medicare Part D in 2027?
For 2027, the annual out-of-pocket prescription drug cap rises to $2,400 and the maximum deductible increases to $700, according to the Centers for Medicare & Medicaid Services. You can also review specific plan impacts using the UnitedHealthcare Part D Guide.
Cost and Limit Changes
- Out-of-Pocket Cap: The maximum amount you pay for covered drugs increases from $2,100 to $2,400. Once you reach this limit, your covered drugs cost $0 for the rest of the year.
- Deductible: The standard deductible rises from $615 to $700.
- Zero Cost-Sharing: After meeting the out-of-pocket limit, you pay nothing for covered prescription drugs.
Premiums and Subsidies
- Subsidy Ending: A temporary federal program (the Premium Stabilization Demonstration) that helped hold down standalone drug plan premiums ends after 2026.
- Premium Impact: Standalone Part D plan premiums may increase because this temporary federal support is expiring.
Lower Drug Prices
- Negotiated Prices: Lower negotiated prices take effect for 15 additional high-spending prescription drugs starting January 1, 2027.
- Savings: This negotiation program aims to lower out-of-pocket costs for popular medications.
Continuing Protections
- Insulin Cap: Your monthly cost for each covered insulin product stays capped at $35, with no deductible.
- Vaccines: Recommended adult vaccines, including shingles and RSV shots, remain free.
- Payment Plan: The Medicare Prescription Payment Plan lets you spread your drug costs across the year instead of paying large sums all at once.